Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

284.70
+9.503.45%
Pre-market: 285.000.3000+0.11%08:48 EDT
Volume:248.81K
Turnover:70.43M
Market Cap:5.68B
PE:29.32
High:285.51
Open:279.51
Low:273.10
Close:275.20
52wk High:326.63
52wk Low:163.45
Shares:19.94M
Float Shares:19.35M
Volume Ratio:1.19
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.87
PE(LYR):46.44

Loading ...

May 04, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Mar 23, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Mar 23, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2022

Major Issues Report

8-K - Current report
Jan 14, 2022

Major Issues Report

8-K - Current report
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 16, 2021

Major Issues Report

8-K - Current report
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Major Issues Report

8-K - Current report
Jul 21, 2021

Major Issues Report

8-K - Current report